Authors:
BREWSTER ME
POP E
FOLTZ RL
REUSCHEL S
GRIFFITH W
AMSELEM S
BIEGON A
Citation: Me. Brewster et al., CLINICAL PHARMACOKINETICS OF ESCALATING IV DOSES OF DEXANABINOL (HU-211), A NEUROPROTECTANT AGENT, IN NORMAL VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 361-365
Authors:
BOUVILLE A
ECKERMAN K
GRIFFITH W
HOFFMAN O
LEGGETT R
STUBBS J
Citation: A. Bouville et al., EVALUATING THE RELIABILITY OF BIOKINETIC AND DOSIMETRIC MODELS AND PARAMETERS USED TO ASSESS INDIVIDUAL DOSES FOR RISK ASSESSMENT PURPOSES, Radiation protection dosimetry, 53(1-4), 1994, pp. 211-215
Authors:
ANSOBORLO E
HENGENAPOLI MH
DONNADIEUCLARAZ M
ROY M
PIHET P
BAILEY MR
MMODY JC
STRADLING GN
BRITCHER AR
WRENN ME
COLLIER CG
FOSTER PP
HODGSON A
METIVIER H
HOCK R
SMITH JRH
BOUVILLE A
ECKERMAN K
GRIFFITH W
HOFFMANN O
LEGGETT R
STUBBS J
BIRCHALL A
Citation: E. Ansoborlo et al., ASSESSMENT OF EXPOSURE - DISCUSSION, Radiation protection dosimetry, 53(1-4), 1994, pp. 217-218
Citation: T. Hudlicky et al., CHEMOENZYMATIC SYNTHESIS OF D-ERYTHRO-C-18-SPHINGOSINES AND L-THREO-C-18-SPHINGOSINES, Journal of organic chemistry, 59(26), 1994, pp. 7944-7946